Leadership Overview
Mars Veterinary has 4 executives leading key functions including financial strategy, global fiscal oversight, clinical medical standards, and external medical affairs.
Driven by a commitment to pet wellbeing, Mars Veterinary advances global veterinary care through scientific innovation, data-driven clinical excellence, and a vast network of specialized health facilities.
Driven by a commitment to pet wellbeing, Mars Veterinary advances global veterinary care through scientific innovation, data-driven clinical excellence, and a vast network of specialized health facilities.
Leadership Roles at Mars Veterinary
Tatsuhiko Miyamoto - Chief Financial Officer, At Vca (Japan)
Tatsuhiko Miyamoto, the Chief Financial Officer, At Vca (Japan) at Mars Veterinary, directs all fiscal operations within the Japanese market. Managing regional capital allocation, the Chief Financial Officer, At Vca (Japan) ensures financial stability across local clinics while supporting the broader organizational mission of high-quality pet care. Miyamoto architects robust budgeting frameworks that allow for the integration of advanced veterinary technologies into daily practice. By analyzing regional market trends, Miyamoto optimizes resource distribution to enhance service delivery. This leadership role involves close collaboration with global finance teams to maintain alignment with international standards. Through rigorous oversight of regional expenditures, Tatsuhiko Miyamoto secures the necessary funding for clinical expansion and equipment upgrades. Ultimately, the Chief Financial Officer, At Vca (Japan) drives sustainable growth by balancing operational efficiency with the high standards of care required for pets throughout the region.
Ted Stedem - Global Chief Financial Officer, Mars Veterinary Health
Ted Stedem, the Global Chief Financial Officer, Mars Veterinary Health at Mars Veterinary, manages the entire financial architecture for the global organization. Overseeing fiscal strategy across 3,000 clinics, the Global Chief Financial Officer, Mars Veterinary Health ensures the long-term viability of the company's mission to improve pet health. Stedem directs global investment initiatives, focusing on the acquisition of new technologies and the scaling of specialty care services. By coordinating with the Board and executive leadership, the Global Chief Financial Officer, Mars Veterinary Health aligns financial performance with the company's commitment to scientific breakthroughs. Ted Stedem monitors international revenue streams to support the 70,000 associates working within the network. Through precise financial modeling and risk management, Stedem maintains the economic health of the enterprise. This leadership role requires constant evaluation of global market conditions to sustain the organization's position as a leader in veterinary medicine.
Molly McAllister - Chief Medical Officer
Molly McAllister, the Chief Medical Officer at Mars Veterinary, defines the clinical standards and medical protocols across the global network. Directing the integration of data-driven insights into daily practice, the Chief Medical Officer ensures that all 12,000 veterinarians provide consistent, high-quality care. McAllister architects medical programs that leverage advanced technology to improve patient outcomes in preventive and emergency settings. By collaborating with clinical teams, the Chief Medical Officer fosters an environment of continuous learning and scientific advancement. Molly McAllister oversees the implementation of evidence-based medicine to enhance the wellbeing of pets worldwide. This leadership role involves setting the strategic direction for clinical research and professional development for veterinary staff. Through the application of extensive data analytics, McAllister drives improvements in diagnostic accuracy and treatment efficacy. Ultimately, the Chief Medical Officer supports the company's mission by ensuring that every clinic maintains the highest possible standards of veterinary excellence.
Todd Tams - Chief Medical Officer, External Affairs
Todd Tams, the Chief Medical Officer, External Affairs at Mars Veterinary, manages relationships with the broader veterinary community and academic institutions. Overseeing external partnerships, the Chief Medical Officer, External Affairs ensures that the company remains at the forefront of scientific discourse and industry innovation. Tams directs initiatives that connect internal clinical expertise with external research, facilitating the exchange of knowledge to benefit the global pet population. By representing the organization in professional forums, the Chief Medical Officer, External Affairs promotes the company's commitment to high-quality care and scientific integrity. Todd Tams coordinates with external stakeholders to advance the understanding of complex veterinary conditions and treatment methodologies. This leadership role involves shaping the company's public medical profile and fostering collaborations that drive industry-wide progress. Through strategic engagement with the veterinary profession, Tams strengthens the organization's reputation as a pioneer in pet health and medical research.
Explore Leadership Teams in Business Services
Riverside Research operates as a not-for-profit scientific research organization dedicated to advancing technological innovation and solving complex challenges for government agencies and the broader public interest. The organization maintains a commitment to conducting rigorous, mission-critical research that addresses national priorities and contributes to scientific advancement across multiple disciplines. The organization has developed substantial expertise in applied research, systems analysis, and technical problem-solving. Riverside Research brings together multidisciplinary teams of scientists, engineers, and researchers who collaborate on projects spanning defense technology, information systems, advanced analytics, and strategic research initiatives. This collaborative approach enables the organization to tackle sophisticated technical challenges that require integration of multiple scientific and engineering domains. Riverside Research delivers comprehensive research and development services that translate scientific discovery into practical solutions. The organization's work encompasses fundamental research, applied development, testing and evaluation, and technical consulting. By maintaining independence as a not-for-profit entity, Riverside Research operates with flexibility to pursue research directions aligned with national needs while maintaining objectivity and scientific rigor in its investigations and analyses.
Company Leadership
EF
KC
BS
Beam Therapeutics is a biotechnology company developing precision genetic medicines using base editing. The company advances research and clinical programs aimed at providing durable treatments for serious diseases, supported by scientific leadership and drug development capabilities. Beam focuses on translating genome editing science into potential lifelong therapies for patients.
Company Leadership JE
CB
GC
AWTA Ltd is the world's largest wool testing organization, providing independent and objective wool certification services. The company operates through three Australian divisions, offering services in wool testing, agrifood technology, and independent material testing. AWTA empowers farmers, growers, processors, and manufacturers with trusted testing and data-driven insights to enhance the quality and safety of agricultural products. With a commitment to innovation and rigorous testing standards, AWTA sets the benchmark for wool assessment and transforms how wool is valued and traded globally.
Company Leadership KC
AW
PW
NI
Microbac Laboratories is a provider of laboratory testing for environmental, food and life sciences. Microbac was founded in 1969 and is currently headquartered in Pittsburgh, PA
Company Leadership RA
DF
CL
Frequently Asked Questions Regarding Mars Veterinary Top Executives and Leadership Team
